DIRECT COMPARISON OF TC-99M DTPA AND TC-99M HMPAO FOR EVALUATING BRAIN-DEATH

被引:27
|
作者
SPIETH, ME
ANSARI, AN
KAWADA, TK
KIMURA, RL
SIEGEL, ME
机构
[1] UNIV SO CALIF,LOS ANGELES CTY MED CTR,SCH MED,DEPT RADIOL,DIV NUCL MED,LOS ANGELES,CA 90033
[2] PACIFIC UNION COLL,ANGWIN,CA
关键词
D O I
10.1097/00003072-199410000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Portable cerebral perfusion studies provide a quick and accurate alternative to traditional confirmatory examinations (such as four-vessel angiography and electroencephalography) to determine brain death. The authors retrospectively analyzed 26 cerebral perfusion studies using both Tc-99m DTPA and Tc-99m HMPAO. The flow agents gave identical results. Additionally, the delayed-phase Tc-99m HMPAO images gave the same results for brain death (14 positive and 12 negative) as the flow images from either agent. Because the Tc-99m HMPAO delayed images can be used for diagnosis, many technical problems become less crucial. Unlike Tc-99m DTPA, Tc-99m HMPAO normally visualizes the gray mater of the cerebellum, midbrain, and medulla. These areas must be evaluated to ensure that they meet the strict criteria for brain death. These differences and the present study suggest that Tc-99m HMPAO is a superior agent for cerebral perfusion studies to determine brain death.
引用
收藏
页码:867 / 872
页数:6
相关论文
共 50 条
  • [41] TC-99M PROPYLENEAMINE OXIME (TC-99M PNAO) - A POTENTIAL BRAIN RADIOPHARMACEUTICAL
    VOLKERT, WA
    TROUTNER, DE
    HOFFMAN, TJ
    SEGER, RM
    HOLMES, RA
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P128 - P128
  • [42] TC-99M (TC-99M) MERCAPTOACETYLTRIGLYCINE - UPDATE ON THE NEW TC-99M RENAL TUBULAR FUNCTION AGENT
    ESHIMA, D
    TAYLOR, A
    SEMINARS IN NUCLEAR MEDICINE, 1992, 22 (02) : 61 - 73
  • [43] BIOKINETICS OF BONE TRACERS BY MEANS OF DECONVOLUTION ANALYSIS - COMPARISON OF TC-99M MDP, TC-99M DPD AND TC-99M EHDP
    KNOP, J
    STRITZKE, P
    KROGER, E
    SCHNEIDER, C
    WASMUS, G
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 1982, 21 (04): : 145 - 149
  • [44] CORRELATIONS BETWEEN TC-99M DTPA CLEARANCE, TC-99M DMSA FIXATION, AND CREATININE CLEARANCE
    CHEVET, D
    LEPOGAMP, P
    LEJEUNE, JJ
    MOISAN, A
    HERRY, JY
    KIDNEY INTERNATIONAL, 1980, 18 (01) : 136 - 136
  • [45] In-vitro adsorption of Tc-99m MIBI, Tc-99m tetrofosmin, Tc-99m furifosmin and Tc-99m O4- onto tubes
    Rodrigues, M
    Chehne, F
    Sinzinger, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1262 - 1262
  • [46] Statistical parametric mapping demonstrates asymmetric uptake with Tc-99m ECD and Tc-99m HMPAO SPECT in normal brain
    Brinkmann, Benjamin H.
    Jones, David T.
    Stead, Matt
    Kazemi, Noojan
    O'Brien, Terence J.
    So, Elson L.
    Blumenfeld, Hal
    Mullan, Brian P.
    Worrell, Gregory A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (01): : 190 - 198
  • [47] DIRECT LABELING WITH TC-99M
    ECKELMAN, WC
    STEIGMAN, J
    NUCLEAR MEDICINE AND BIOLOGY, 1991, 18 (01): : 3 - 7
  • [48] DIAGNOSIS OF BRAIN-DEATH USING TC-99M-HMPAO SPECT, TC-99M-DTPA SCINTIGRAPHY AND RADIONUCLIDE ANGIOGRAPHY
    ERBENGI, G
    ERBENGI, A
    ERBAS, B
    ARAS, T
    NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE, 1990, 21 (05): : 177 - 179
  • [49] TC-99M HMPAO LABELED LEUKOCYTES FOR BONE-MARROW SCINTIGRAPHY - COMPARISON TO TC-99M HSA COLLOIDS RESULTS
    BOURGEOIS, P
    STEGEN, M
    DEMONCEAU, G
    FEREMANS, W
    BRACOPS, CHJ
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (07) : 1320 - 1320
  • [50] Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma
    Kim, SJ
    Kim, IJ
    Kim, YK
    CLINICAL NUCLEAR MEDICINE, 2002, 27 (01) : 30 - 33